Patent protection of the CRISPR/Cas9 technology - a contribution from our partner Dr. Maxien in the latest issue of BIOspektrum
For years, two US universities have been struggling over who is entitled to patent protection for the CRISPR/Cas9 technology respectively who invented it (first): on one side are the University of California (UC) and the two Nobel Prize winners Emmanuel Charpentier and Jennifer Doudna, and on the…
read